Supplementary Table 2 from Prospective Examination of Cellular and Soluble Mediators of Immune Dysregulation and Their Association with Lung Cancer Risk

Authors:

Open Access

Cytokine Biomarkers of the 54-Plex Immunoassay (Meso Scale Discovery) during Phase I of the study.